Frazier Management LLC Arcutis Biotherapeutics, Inc. Transaction History

Frazier Management LLC

  • $0
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$14.38 - $22.79 $121 Million - $192 Million
-8,434,232 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$24.42 - $34.75 $51.5 Million - $73.3 Million
-2,108,558 Reduced 20.0%
8,434,232 $230 Million
Q1 2020

May 13, 2020
BUY
$18.5 - $36.9 $195 Million - $389 Million
10,542,790 New
10,542,790 $314 Million

Others Institutions Holding ARQT

# of Institutions
197
Shares Held
129M
Call Options Held
738K
Put Options Held
82K
View Full List

About Arcutis Biotherapeutics, Inc.

ARQT Quotes by TradingView
  • Ticker ARQT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,187,500
  • Market Cap $902M
  • Description
  • Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...
More about ARQT
Track This Portfolio

Track Frazier Management LLC Portfolio

Follow Frazier Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email